Innovation at Penn
Browse Penn-owned technologies available for licensing.
Search Results - maclean+nasrallah
Rapid and ultrasensitive profiling of EGFRvIII mutations in cancer and normal tissue
A method to rapidly detect the presence of EGFRvIII mutations in cancers and normal tissue using digital PCR. Problem: Glioblastoma multiforme (GBM) is a devastating brain cancer with poor prognosis. EGFRvIII is a mutation in the Extracellular Growth Factor Receptor that frequently occurs in GBM tumors. Targeting EGFRvIII mutations is an emerging...
Chemical Processes and Synthesis
Research Tools & Reagents
© 2021. All Rights Reserved. Powered by